Key terms

About MMSI

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MMSI news

Mar 19 9:30am ET Merit Medical launches Micro ACE Advanced Micro-Access System Mar 01 7:30am ET Merit Medical price target raised to $85 from $81 at Wells Fargo Mar 01 4:56am ET Hold Rating on Merit Medical Systems Amid Modest Growth Projections and Market Caution Feb 29 9:20am ET Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Merit Medical Systems (MMSI) Feb 29 9:04am ET Merit Medical price target raised to $98 from $96 at Barrington Feb 29 8:44am ET Merit Medical price target raised to $88 from $81 at Needham Feb 29 8:20am ET Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Cooper Co (COO) Feb 29 7:50am ET Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Natera (NTRA) Feb 29 7:40am ET Merit Medical price target raised to $112 from $102 at Canaccord Feb 29 6:05am ET Merit Medical Systems Earns ‘Buy’ Rating on Strong Q4 Performance and Promising Growth Outlook Feb 28 4:33pm ET Merit Medical Systems Unveils Growth Plans in Earnings Call Feb 28 4:13pm ET Merit Medical sees FY24 EPS $3.28-$3.35, consensus $3.32 Feb 28 4:12pm ET Merit Medical reports Q4 EPS 81c, consensus 76c Feb 15 9:28am ET Merit Medical receives 501(k) clearance for SCOUT MD Surgical Guidance System Feb 07 10:32am ET Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls Feb 07 6:08am ET BofA starts Merit Medical at Neutral, sees 10% upside Feb 07 6:04am ET Merit Medical initiated with a Neutral at BofA Jan 26 9:15am ET Buy Rating on Merit Medical Systems Backed by Strong Growth and Positive Q4 Outlook Jan 22 7:02am ET Merit Medical price target raised to $102 from $100 at Canaccord Jan 16 4:14pm ET Merit Medical enrolls first patient in Motion study Jan 16 4:13pm ET Merit Medical enrolls first patient in MOTION study Jan 12 7:36am ET Merit Medical Systems (MMSI) Gets a Buy from Piper Sandler Jan 12 7:29am ET Merit Medical price target raised to $95 from $88 at Piper Sandler Jan 12 5:47am ET Hold Rating on Merit Medical Systems Amid Mixed Growth Signals and Pending Wrapsody Impact Jan 09 5:09am ET Hold Rating on Merit Medical Systems Amid Growth and Awaited Financial Details Jan 08 1:25pm ET Merit Medical Systems Surpasses Q4 Revenue Expectations, Secures Buy Rating Jan 08 9:06am ET Merit Medical report FY23 preliminary revenue $1.255B-$1.259B, consensus $1.25B Dec 21 7:33am ET Merit Medical upgraded to Buy from Hold at Canaccord

No recent news articles are available for MMSI

No recent press releases are available for MMSI

MMSI Financials

1-year income & revenue

Key terms

MMSI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MMSI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms